UAE Implements Liflevendra for Cholesterol
The Emirates Pharmacy Foundation has approved the medication "Lipfendra" for the treatment of elevated levels of harmful cholesterol (LDL-C) in adults, including certain genetic cases, as part of a treatment plan prescribed by a doctor. The UAE has become the second country worldwide to approve this therapy, which is taken orally once daily and helps reduce LDL-C levels alongside a healthy lifestyle, with the goal of decreasing the risk of cardiovascular diseases and enhancing the quality of healthcare.
Size: 120%Text Size
Notice: This Is an AI-Generated Summary
Comments (0)